Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
BDC
MCID: CLL002
MIFTS: 44

Collecting Duct Carcinoma (BDC)

Categories: Cancer diseases, Nephrological diseases, Rare diseases
Genes Variations Tissues Related diseases Publications Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Collecting Duct Carcinoma

About this section

MalaCards integrated aliases for Collecting Duct Carcinoma:

Name: Collecting Duct Carcinoma 12 54 60 15 17
Kidney Medullary Carcinoma 54 17 74
Renal Medullary Carcinoma 12 54 60
Collecting Duct Carcinoma of the Kidney 54 74
Bellini Duct Carcinoma 54 60
Bellini Carcinoma 54 60
Bdc 54 60
Cdc 54 60
Renal Carcinoma, Collecting Duct Type 12
Carcinoma of Renal Collecting Duct 12
Renal Collecting Duct Carcinoma 54

Characteristics:

Orphanet epidemiological data:

60
collecting duct carcinoma
Inheritance: Not applicable; Age of onset: Adult;

Classifications:

MalaCards categories:
Global: Rare diseases Cancer diseases
Anatomical: Nephrological diseases
See all MalaCards categories (disease lists)
ICD10: 35
Orphanet: 60  
Rare renal diseases


External Ids:

Disease Ontology 12 DOID:4464
MeSH 45 D002292
NCIt 51 C6194
MESH via Orphanet 46 D002292
ICD10 via Orphanet 35 C64
UMLS via Orphanet 75 C1266044
Sources

Summaries for Collecting Duct Carcinoma

About this section
NIH Rare Diseases : 54 Collecting duct carcinoma (CDC) is a rare and aggressive form of kidney cancer that begins in the collecting duct of the kidney. Many people with CDC have no signs or symptoms until the cancer is at an advanced stage. Symptoms may include flank pain, unexplained weight loss, or blood in the urine. Although it can affect people of all ages, CDC tends to occur in younger patients. The exact cause of CDC is unknown. It usually occurs in people with no family history of the condition. Treatment options for CDC may include surgery and/or chemotherapy.

MalaCards based summary : Collecting Duct Carcinoma, also known as kidney medullary carcinoma, is related to renal cell carcinoma, nonpapillary and spindle cell carcinoma, and has symptoms including flank pain An important gene associated with Collecting Duct Carcinoma is XIST (X Inactive Specific Transcript). The drugs Sunitinib and Sorafenib have been mentioned in the context of this disorder. Affiliated tissues include kidney, bone and pancreas.

Disease Ontology : 12 A renal cell carcinoma that begins in distal collecting ducts of the kidney with a tubulopapillary morphology and intracytoplasmic mucicarminophilic material.

Wikipedia : 77 Collecting duct carcinoma (CDC) (also known as Bellini duct carcinoma), is a type of kidney cancer that... more...

Sources

Related Diseases for Collecting Duct Carcinoma

About this section

Diseases related to Collecting Duct Carcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 246)
# Related Disease Score Top Affiliating Genes
1 renal cell carcinoma, nonpapillary 31.9 AMACR KRT7 MME PAX8 SETD2
2 spindle cell carcinoma 29.9 AMACR KRT7
3 chromophobe renal cell carcinoma 29.7 KRT7 MME
4 oncocytoma 29.7 AMACR KRT7 MME
5 renal cell carcinoma, papillary, 1 29.3 AMACR KRT7 MME PAX8 SETD2
6 clear cell renal cell carcinoma 29.2 KRT7 MME PAX8 PBRM1 SETD2
7 brachydactyly, type c 11.4
8 chagas disease 11.4
9 bazex syndrome 11.3
10 tetanus 11.3
11 traumatic brain injury 11.3
12 zika virus infection 11.3
13 rabies 11.2
14 diphtheria 11.2
15 acute flaccid myelitis 11.2
16 nodding syndrome 11.2
17 renal cell carcinoma, xp11-associated 11.2
18 angioedema, hereditary, type i 11.1
19 grant syndrome 11.1
20 coloboma of optic nerve 10.9
21 coumarin resistance 10.9
22 diabetes insipidus, neurohypophyseal 10.9
23 skin creases, congenital symmetric circumferential, 1 10.9
24 glycogen storage disease ii 10.9
25 nicolaides-baraitser syndrome 10.9
26 duane-radial ray syndrome 10.9
27 salmonellosis 10.9
28 folliculitis 10.9
29 dermatophytosis 10.9
30 toxocariasis 10.9
31 congenital rubella 10.9
32 congenital zika syndrome 10.9
33 influenza 10.4
34 hepatitis 10.3
35 nephrogenic adenoma of urinary bladder 10.3 KRT7 PAX8
36 bladder benign neoplasm 10.3 KRT7 PAX8
37 vulvar sarcoma 10.3 KRT7 SMARCB1
38 anthrax disease 10.3
39 endosalpingiosis 10.2 KRT7 PAX8
40 renal pelvis adenocarcinoma 10.2 KRT7 PAX8
41 sensory organ benign neoplasm 10.2 KRT7 PAX8
42 endocervical carcinoma 10.2 KRT7 PAX8
43 renal pelvis carcinoma 10.2 KRT7 PAX8
44 peritoneum cancer 10.2 KRT7 PAX8
45 epithelial-myoepithelial carcinoma 10.2 KRT7 SMARCB1
46 endocervical adenocarcinoma 10.2 KRT7 PAX8
47 renal adenoma 10.2 AMACR KRT7
48 papillary adenoma 10.2 AMACR KRT7
49 epithelial predominant wilms' tumor 10.2 AMACR KRT7
50 cervical adenosquamous carcinoma 10.2 KRT7 PAX8

Graphical network of the top 20 diseases related to Collecting Duct Carcinoma:



Diseases related to Collecting Duct Carcinoma
Sources

Symptoms & Phenotypes for Collecting Duct Carcinoma

About this section

UMLS symptoms related to Collecting Duct Carcinoma:


flank pain
Sources

Drugs & Therapeutics for Collecting Duct Carcinoma

About this section

Drugs for Collecting Duct Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 46)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Sunitinib Approved, Investigational Phase 2 557795-19-4, 341031-54-7 5329102
2
Sorafenib Approved, Investigational Phase 2 284461-73-0 216239 406563
3
Cisplatin Approved Phase 2 15663-27-1 441203 84093 2767
4
Gemcitabine Approved Phase 2 95058-81-4 60750
5
Bevacizumab Approved, Investigational Phase 2 216974-75-3
6
nivolumab Approved Phase 2,Phase 1 946414-94-4
7
Ipilimumab Approved Phase 2,Phase 1 477202-00-9
8
Daunorubicin Approved Phase 2 20830-81-3 30323
9
Doxorubicin Approved, Investigational Phase 2 23214-92-8 31703
10
Ixazomib Approved, Investigational Phase 2 1072833-77-2
11
Pembrolizumab Approved Phase 2 1374853-91-4
12
Miconazole Approved, Investigational, Vet_approved Phase 2,Phase 1 22916-47-8 4189
13
Sirolimus Approved, Investigational Phase 2 53123-88-9 46835353 6436030 5284616
14
Everolimus Approved Phase 2 159351-69-6 6442177 70789204
15
Vidarabine Approved, Investigational Phase 1, Phase 2 24356-66-9 21704 32326
16
Mycophenolic acid Approved Phase 1, Phase 2 24280-93-1 446541
17
Fludarabine Approved Phase 1, Phase 2,Phase 2 75607-67-9, 21679-14-1 30751
18
Glycine Approved, Nutraceutical, Vet_approved Phase 2 56-40-6 750
19
Doxil Approved June 1999 Phase 2 31703
20 Angiogenesis Inhibitors Phase 2
21 Protein Kinase Inhibitors Phase 2
22 Angiogenesis Modulating Agents Phase 2
23 Antimetabolites, Antineoplastic Phase 2,Phase 1
24 Immunologic Factors Phase 2,Phase 1
25 Antiviral Agents Phase 2,Phase 1
26 Antimetabolites Phase 2,Phase 1
27 Anti-Infective Agents Phase 2,Phase 1
28 Immunosuppressive Agents Phase 2,Phase 1
29 Antineoplastic Agents, Immunological Phase 2,Phase 1
30 Topoisomerase Inhibitors Phase 2
31 Antibiotics, Antitubercular Phase 2,Phase 1
32
protease inhibitors Phase 2
33 Neurotransmitter Agents Phase 2
34 HIV Protease Inhibitors Phase 2
35 Anti-Bacterial Agents Phase 2,Phase 1
36 lysine Phase 2,Phase 1
37 Antibodies, Monoclonal Phase 2,Phase 1
38 Immunoglobulins Phase 2,Phase 1
39 Antibodies Phase 2,Phase 1
40 Antifungal Agents Phase 2,Phase 1
41 Vidarabine Phosphate Phase 1, Phase 2
42 Antitubercular Agents Phase 1, Phase 2
43 Antirheumatic Agents Phase 1, Phase 2
44 Calcineurin Inhibitors Phase 1, Phase 2
45 Dermatologic Agents Phase 1, Phase 2
46 Cyclosporins Phase 1, Phase 2

Interventional clinical trials:

(show all 16)
# Name Status NCT ID Phase Drugs
1 Trial Of Sunitinib In Advanced Non-Clear Cell Type Renal Cell Carcinoma Unknown status NCT01219751 Phase 2 Sunitinib
2 Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma Completed NCT01762150 Phase 2 Sorafenib;Gemcitabine;Cisplatin
3 Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer Completed NCT00465179 Phase 2 Sunitinib Malate
4 Study of Gemcitabine+Platinium Salt+Bevacizumab Combination for Metastatic Collecting Duct Carcinoma (GETUG-AFU 24) Recruiting NCT02363751 Phase 2 Bevacizumab
5 caBozantinib in cOllectiNg ductS Renal Cell cArcInoma Recruiting NCT03354884 Phase 2 cabozantinib
6 Nivolumab Plus Ipilimumab in Patients With Renal Medullary Carcinoma Recruiting NCT03274258 Phase 2 Nivolumab;Ipilimumab
7 Trial of Ixazomib Combined With Gemcitabine and Doxorubicin in Patients With Renal Medullary Carcinoma Recruiting NCT03587662 Phase 2 Doxorubicin;Gemcitabine;Ixazomib
8 A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma Recruiting NCT02601950 Phase 2 Tazemetostat
9 Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic Recruiting NCT02721732 Phase 2
10 Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Active, not recruiting NCT01767636 Phase 2 Pazopanib Hydrochloride
11 Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma Active, not recruiting NCT01185366 Phase 2 Everolimus;Sunitinib
12 Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer Active, not recruiting NCT00027820 Phase 1, Phase 2 Fludarabine Phosphate;Cyclosporine;Mycophenolate Mofetil
13 ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB) Not yet recruiting NCT03685448 Phase 2 Cabozantinib
14 Cabozantinib S-Malate, Nivolumab, and Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors Not yet recruiting NCT03866382 Phase 2 Cabozantinib;Cabozantinib S-malate
15 A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma Recruiting NCT02601937 Phase 1 Tazemetostat
16 Cabozantinib-s-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors Recruiting NCT02496208 Phase 1 Cabozantinib S-malate

Search NIH Clinical Center for Collecting Duct Carcinoma

Sources

Genetic Tests for Collecting Duct Carcinoma

About this section
Sources

Anatomical Context for Collecting Duct Carcinoma

About this section

MalaCards organs/tissues related to Collecting Duct Carcinoma:

42
Kidney, Bone, Pancreas, Thyroid, Neutrophil, Salivary Gland
Sources

Publications for Collecting Duct Carcinoma

About this section

Articles related to Collecting Duct Carcinoma:

(show top 50) (show all 140)
# Title Authors Year
1
Bilateral kidneys involvement of collecting duct carcinoma with cystic change: A case report. ( 30681608 )
2019
2
Rechallenge of carboplatin-gemcitabine based chemotherapy for rapidly progressing metastatic collecting duct carcinoma of the kidney leading to a delayed and durable complete response: A case report. ( 30867800 )
2019
3
Prognostic significance of neutrophil-to-lymphocyte ratio in collecting duct carcinoma. ( 29846639 )
2018
4
Sorafenib in combination with gemcitabine plus cisplatin chemotherapy in metastatic renal collecting duct carcinoma: A prospective, multicentre, single-arm, phase 2 study. ( 29933095 )
2018
5
Management of Metastatic Collecting Duct Carcinoma: An Encouraging Result in a Patient Treated With Cabozantinib. ( 29656939 )
2018
6
Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma. ( 29309300 )
2018
7
BK virus-associated collecting duct carcinoma of the renal allograft in a kidney-pancreas allograft recipient. ( 29599935 )
2018
8
Collecting duct carcinoma kidney masquerading as hydatid cyst: A rare case report and review of literature. ( 30004068 )
2018
9
A Composite Renal Tumor with Dual Differentiation, Chromophobe and Collecting Duct Carcinoma. ( 30228921 )
2018
10
Nivolumab therapy for metastatic collecting duct carcinoma after nephrectomy: A case report. ( 30407350 )
2018
11
Clinicopathologic and Molecular Pathology of Collecting Duct Carcinoma and Related Renal Cell Carcinomas. ( 28181950 )
2017
12
A Case of Metastatic Collecting Duct Carcinoma Whose Massive Skull Bone Metastasis was Prominently Reossified by Gemcitabine Plus Cisplatin Chemotherapy Combined with Zoledronic Acid. ( 28932690 )
2017
13
Sarcomatoid Renal Cell Carcinoma and Collecting Duct Carcinoma: Discrimination From Common Renal Cell Carcinoma Subtypes and Benign RCC Mimics on Multiphasic MDCT. ( 28528853 )
2017
14
Response to nivolumab in metastatic collecting duct carcinoma expressing PD-L1: A case report. ( 29285361 )
2017
15
Collecting Duct Carcinoma of the Native Kidney in a Renal Transplant Recipient. ( 29062581 )
2017
16
Collecting duct carcinoma of the kidney: Disease characteristics and treatment outcomes from the National Cancer Database. ( 28495554 )
2017
17
Anti-programmed Death Receptor 1 Blockade Induces Clinical Response in a Patient With Metastatic Collecting Duct Carcinoma. ( 27021586 )
2016
18
Collecting Duct Carcinoma With Cardiac Metastases: A Case Report &A Literature Review. ( 26977410 )
2016
19
A renal adenocarcinoma in a corn snake (Pantherophis guttatus) resembling human collecting duct carcinoma. ( 27493139 )
2016
20
Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation. ( 27144525 )
2016
21
Enhanced MRI and 18F-FDG PET/CT Findings of Preoperative Primary Renal Collecting Duct Carcinoma. ( 27775947 )
2016
22
Targeted Therapy in Collecting Duct Carcinoma of the Kidney: A Case Report and Literature Review. ( 26684811 )
2016
23
Retraction Note: Collecting duct carcinoma of the kidney: a clinicopathological study of five cases. ( 25884188 )
2015
24
Collecting duct carcinoma of the kidney: A case report. ( 26137167 )
2015
25
Papillary renal cell carcinoma and collecting duct carcinoma combination. A case report and review of synchronous renal cell carcinoma subtypes in the same kidney. ( 26170866 )
2015
26
Comparative study of CT appearances in mucinous tubular and spindle cell carcinoma and collecting duct carcinoma of the kidney. ( 26435393 )
2015
27
Characterization of Clinical Cases of Collecting Duct Carcinoma of the Kidney Assessed by Comprehensive Genomic Profiling. ( 26149668 )
2015
28
Collecting duct carcinoma versus renal medullary carcinoma: an appeal for nosologic and biological clarity. ( 24805860 )
2014
29
Clinical features and treatment of collecting duct carcinoma of the kidney from the korean cancer study group genitourinary and gynecology cancer committee. ( 24851105 )
2014
30
Collision tumor of the kidney composed of clear cell carcinoma and collecting duct carcinoma: report of a case with unusual morphology and clinical follow-up. ( 24589208 )
2014
31
Treatment of collecting duct carcinoma: current status and future perspectives. ( 24511050 )
2014
32
A collecting duct carcinoma producing carcinoembryonic antigen and Ca-125 in a 29-year-old woman. ( 24531923 )
2014
33
Collecting duct carcinoma of the kidney. A contribution of 4 new cases. ( 25306992 )
2014
34
Composite chromophobe renal cell carcinoma with sarcomatoid differentiation containing osteosarcoma, chondrosarcoma, squamous metaplasia and associated collecting duct carcinoma: a case report. ( 25291862 )
2014
35
Collecting duct carcinoma of the kidney: Imaging observations of a rare tumor. ( 24396480 )
2014
36
Salivary gland-type renal carcinoma, a subset of collecting duct carcinoma: case report and meta-analysis of the entity. ( 23339365 )
2013
37
The MSCT and MRI findings of collecting duct carcinoma. ( 23726725 )
2013
38
Management of renal collecting duct carcinoma: a systematic review and the McMaster experience. ( 23737692 )
2013
39
Active targeted therapy for metastatic collecting duct carcinoma of the kidney: a case report and review of the literature. ( 23686671 )
2013
40
Renal collecting duct carcinoma: report of a case with unusual imaging findings regarding renal function. ( 23771391 )
2013
41
Collecting duct carcinoma: a rare malignancy. ( 23575082 )
2013
42
The multislice CT findings of renal carcinoma associated with XP11.2 translocation/TFE gene fusion and collecting duct carcinoma. ( 23446748 )
2013
43
Collecting duct carcinoma of the kidney: a clinicopathological study of five cases. ( 23773436 )
2013
44
Triple combination of bevacizumab, gemcitabine and platinum salt in metastatic collecting duct carcinoma. ( 24190963 )
2013
45
Renal collecting duct carcinoma with extensive coagulative necrosis mimicking anemic infarct: report of a case and the literature review. ( 23866935 )
2013
46
Distal ureteral seeding metastasis of collecting duct carcinoma manifesting as deep vein thrombosis. ( 22513238 )
2012
47
Tubulocystic renal carcinoma (low grade collecting duct carcinoma). ( 23154610 )
2012
48
Collecting duct carcinoma presenting uncommon metastatic features. ( 23235769 )
2012
49
A case report of collecting duct carcinoma of the kidney coexistent with giant adrenal myelolipoma. ( 22511446 )
2012
50
HER2 blockade in metastatic collecting duct carcinoma (CDC) of the kidney: a case report. ( 23207624 )
2012
Sources

Variations for Collecting Duct Carcinoma

About this section

Cosmic variations for Collecting Duct Carcinoma:

9 (show top 50) (show all 278)
# Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)		 Mutation CDS Mutation AA GRCh38 Location Conf
1 COSM6941466 XIAP kidney,NS,carcinoma,renal cell carcinoma unclassified c.563G>C p.G188A 23:123886225-123886225 0
2 COSM14312 VHL kidney,NS,carcinoma,renal cell carcinoma unclassified c.353T>C p.L118P 3:10146526-10146526 0
3 COSM14380 VHL kidney,NS,carcinoma,renal cell carcinoma unclassified c.548C>A p.S183* 3:10149871-10149871 0
4 COSM18350 VHL kidney,NS,carcinoma,renal cell carcinoma unclassified c.256C>T p.P86S 3:10142103-10142103 0
5 COSM17957 VHL kidney,NS,carcinoma,renal cell carcinoma unclassified c.292T>G p.Y98D 3:10142139-10142139 0
6 COSM14382 VHL kidney,NS,carcinoma,renal cell carcinoma unclassified c.245G>C p.R82P 3:10142092-10142092 0
7 COSM14305 VHL kidney,NS,carcinoma,renal cell carcinoma unclassified c.266T>A p.L89H 3:10142113-10142113 0
8 COSM25676 VHL kidney,NS,carcinoma,renal cell c.485G>T p.C162F 3:10149808-10149808 0
9 COSM17875 VHL kidney,NS,carcinoma,renal cell carcinoma unclassified c.234T>G p.N78K 3:10142081-10142081 0
10 COSM17983 VHL kidney,NS,carcinoma,renal cell carcinoma unclassified c.500G>A p.R167Q 3:10149823-10149823 0
11 COSM18097 VHL kidney,NS,carcinoma,renal cell carcinoma unclassified c.482G>A p.R161Q 3:10149805-10149805 0
12 COSM14425 VHL kidney,NS,carcinoma,renal cell carcinoma unclassified c.341-2A>T p.? 3:10146512-10146512 0
13 COSM17872 VHL kidney,NS,carcinoma,renal cell carcinoma unclassified c.217C>T p.Q73* 3:10142064-10142064 0
14 COSM27269 UMPS kidney,NS,carcinoma,renal cell c.528G>A p.L176L 3:124737785-124737785 0
15 COSM7349320 TSC2 kidney,NS,carcinoma,renal cell carcinoma unclassified c.1119+1G>T p.? 16:2060814-2060814 0
16 COSM7349613 TSC2 kidney,NS,carcinoma,renal cell carcinoma unclassified c.976-1G>A p.? 16:2060669-2060669 0
17 COSM7349594 TSC2 kidney,NS,carcinoma,renal cell carcinoma unclassified c.2356-1G>C p.? 16:2074199-2074199 0
18 COSM7349602 TSC2 kidney,NS,carcinoma,renal cell carcinoma unclassified c.1636G>T p.E546* 16:2065555-2065555 0
19 COSM7349619 TSC2 kidney,NS,carcinoma,renal cell carcinoma unclassified c.390C>G p.Y130* 16:2054349-2054349 0
20 COSM7349321 TSC2 kidney,NS,carcinoma,renal cell carcinoma unclassified c.1600-1G>T p.? 16:2065518-2065518 0
21 COSM7349621 TSC2 kidney,NS,carcinoma,renal cell carcinoma unclassified c.774+1G>A p.? 16:2056770-2056770 0
22 COSM7349639 TSC2 kidney,NS,carcinoma,renal cell carcinoma unclassified c.731G>T p.C244F 16:2056726-2056726 0
23 COSM7349636 TSC2 kidney,NS,carcinoma,renal cell carcinoma unclassified c.1189C>T p.Q397* 16:2061940-2061940 0
24 COSM6957851 TSC2 kidney,NS,carcinoma,renal cell carcinoma unclassified c.541G>A p.V181M 16:2055461-2055461 0
25 COSM7349616 TSC2 kidney,NS,carcinoma,renal cell carcinoma unclassified c.1717-1G>C p.? 16:2070455-2070455 0
26 COSM1272079 TSC2 kidney,NS,carcinoma,renal cell carcinoma unclassified c.3412C>T p.R1138* 16:2080179-2080179 0
27 COSM6943738 TSC2 kidney,NS,carcinoma,renal cell carcinoma unclassified c.975+1G>T p.? 16:2058874-2058874 0
28 COSM7349331 TSC1 kidney,NS,carcinoma,renal cell carcinoma unclassified c.1276G>T p.D426Y 9:132907358-132907358 0
29 COSM6942356 TSC1 kidney,NS,carcinoma,renal cell carcinoma unclassified c.2287C>T p.Q763* 9:132902709-132902709 0
30 COSM6963117 TSC1 kidney,NS,carcinoma,renal cell carcinoma unclassified c.1001C>A p.S334* 9:132911481-132911481 0
31 COSM29770 TSC1 kidney,NS,carcinoma,renal cell carcinoma unclassified c.508+1G>T p.? 9:132923347-132923347 0
32 COSM7349328 TSC1 kidney,NS,carcinoma,renal cell carcinoma unclassified c.1835T>A p.L612* 9:132905743-132905743 0
33 COSM30474 TRIO kidney,NS,carcinoma,renal cell c.9008A>G p.N3003S 5:14508136-14508136 0
34 COSM10656 TP53 kidney,NS,carcinoma,renal cell carcinoma unclassified c.742C>T p.R248W 17:7674221-7674221 0
35 COSM45243 TP53 kidney,NS,carcinoma,renal cell carcinoma unclassified c.374C>G p.T125R 17:7675995-7675995 0
36 COSM10647 TP53 kidney,NS,carcinoma,renal cell carcinoma unclassified c.404G>T p.C135F 17:7675208-7675208 0
37 COSM10659 TP53 kidney,NS,carcinoma,collecting duct carcinoma c.817C>T p.R273C 17:7673803-7673803 0
38 COSM44310 TP53 kidney,NS,carcinoma,renal cell carcinoma unclassified c.738G>A p.M246I 17:7674225-7674225 0
39 COSM6922197 TP53 kidney,NS,carcinoma,renal cell carcinoma unclassified c.97-2A>C p.? 17:7676274-7676274 0
40 COSM45135 TP53 kidney,NS,carcinoma,renal cell carcinoma unclassified c.673-1G>T p.? 17:7674291-7674291 0
41 COSM6929752 TBX3 kidney,NS,carcinoma,renal cell carcinoma unclassified c.510G>T p.W170C 12:114681026-114681026 0
42 COSM6979493 STAG2 kidney,NS,carcinoma,renal cell carcinoma unclassified c.2096+1G>A p.? 23:124065947-124065947 0
43 COSM6975582 STAG2 kidney,NS,carcinoma,renal cell carcinoma unclassified c.1348A>T p.R450* 23:124057909-124057909 0
44 COSM6023628 STAG2 kidney,NS,carcinoma,renal cell carcinoma unclassified c.2860C>T p.R954C 23:124081464-124081464 0
45 COSM6963119 SPOP kidney,NS,carcinoma,renal cell carcinoma unclassified c.265T>G p.L89V 17:49619321-49619321 0
46 COSM6986508 SPEN kidney,NS,carcinoma,renal medullary carcinoma c.2318G>A p.R773K 1:15928558-15928558 0
47 COSM6964939 SMARCB1 kidney,NS,carcinoma,renal cell carcinoma unclassified c.987-2A>T p.? 22:23833570-23833570 0
48 COSM989 SMARCB1 kidney,NS,carcinoma,renal cell carcinoma unclassified c.1130G>A p.R377H 22:23834152-23834152 0
49 COSM1266238 SMARCA4 kidney,NS,carcinoma,renal cell carcinoma unclassified c.3575G>A p.R1192H 19:11033318-11033318 0
50 COSM6975580 SETD2 kidney,NS,carcinoma,renal cell carcinoma unclassified c.4736C>G p.S1579* 3:47062211-47062211 0
Sources

Expression for Collecting Duct Carcinoma

About this section
Search GEO for disease gene expression data for Collecting Duct Carcinoma.
Sources

Pathways for Collecting Duct Carcinoma

About this section
Sources

GO Terms for Collecting Duct Carcinoma

About this section

Biological processes related to Collecting Duct Carcinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 chromatin organization GO:0006325 9.33 PBRM1 SETD2 SMARCB1
2 ATP-dependent chromatin remodeling GO:0043044 8.96 PBRM1 SMARCB1
3 nucleosome disassembly GO:0006337 8.62 PBRM1 SMARCB1
Sources

Sources for Collecting Duct Carcinoma

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....